Form D · Biotechnology

Chemitope Glycopeptide Inc.

Brooklyn, NY · CIK 0001714830

Offering snapshot reported Mar 15, 2019 · SEC filing

Reported sold
$200K
Offering amount: $350K
Investors reported
3
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jul 31, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$100K$200KSep 14, 2017: $100,000.00Sep 14, 2017Mar 15, 2019: $200,000.00Mar 15, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$100,000 → $200,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2019Amendment$200,000$100,000vs Sep 14, 20173SEC filing
Sep 14, 2017Initial$100,000No comparison1SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-294747

Source: Form D, filed Mar 15, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Baptiste Aussedat Director, Executive
William Walkowicz Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
684 Lincoln Place
Brooklyn, NY, 11216